1 Comment

  • Despite the significant drop in efficacy, some experts are anticipating an emergency approval for the drug. Dr. David Boulware, who researches infectious disease at the University of Minnesota, told The New York Times that “The reduction in hospitalization is a little bit less, but there is still a big mortality benefit if you start early.”

    Pfizer has been developing its own oral medication for Covid simultaneously to Merck, and found the treatment to be 89% effective at reducing hospitalization and death.

    The pill, called Paxlovid, has also been submitted for emergency authorization by the FDA. Pfizer officially completed its application for emergency use authorization last week, but it has not yet been announced when the agency will make a decision regarding the drug.

Leave Your Comment